Expertise in
2
conditions

Yongfu F. Wang

41 Linyin Road, 
Baotou, CN 
Expertise in
2
conditions
41 Linyin Road, 
Baotou, CN 

Overview

Yongfu Wang practices practicing medicine in Baotou, China.

Wang is highly rated in 2 conditions, according to our data. Their clinical expertise encompasses Rheumatoid Arthritis (RA), Arthritis, Dry Mouth, and Sjogren Syndrome.

They are actively involved in clinical research, co-authoring 68 peer reviewed articles and participating in 2 clinical trials.

Locations

41 Linyin Road, Baotou, 014010, China

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Multicenter, Randomized, Double-Blind and Placebo-Controlled 16-Week Study Followed by Long Term Evaluation of Efficacy and Safety of Ixekizumab (LY2439821) in Chinese Patients With Radiographic Axial Spondyloarthritis
A Multicenter, Randomized, Double-Blind and Placebo-Controlled 16-Week Study Followed by Long Term Evaluation of Efficacy and Safety of Ixekizumab (LY2439821) in Chinese Patients With Radiographic Axial Spondyloarthritis
Enrollment Status: Completed
Publish Date: April 14, 2023
Intervention Type: Drug
Study Drug: Ixekizumab
Study Phase: Phase 3
A Phase Ⅱ Study to Evaluate the Efficacy and Safety of Hemay005 in the Treatment of Behçet Disease
A Phase Ⅱ Study to Evaluate the Efficacy and Safety of Hemay005 in the Treatment of Behçet Disease
Enrollment Status: Terminated
Publish Date: June 21, 2022
Intervention Type: Drug, Other
Study Drug: Hemay005
Study Phase: Phase 2
View 1 Less Clinical Trial

68 Total Publications

Cyclodextrin Inhibits Caveolin-1 to Regulate CD4+ T Cell Subset Differentiation and Ameliorate Rheumatoid Arthritis Progression.
Cyclodextrin Inhibits Caveolin-1 to Regulate CD4+ T Cell Subset Differentiation and Ameliorate Rheumatoid Arthritis Progression.
Journal: Journal of immunology research
Published: February 02, 2026

Frequently Asked Questions about Yongfu F. Wang

Is Yongfu F. Wang a top-rated expert for Rheumatoid Arthritis (RA)?

MediFind is an objective health platform that identifies experts based on real-world data. Yongfu F. Wang is classified as an Advanced expert for Rheumatoid Arthritis (RA), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Yongfu F. Wang participate in research or clinical trials?

Yes. Yongfu F. Wang has published 68 articles and abstracts on conditions like Rheumatoid Arthritis (RA). You can view a list of Yongfu F. Wang's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Wang's expertise for a condition
ConditionClose
      View All 21 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile